Global Nuclear Medicine/Radiopharmaceuticals Market 2018 - Industry Research Report

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE
 

Global Nuclear Medicine/Radiopharmaceuticals Market 2018 - Industry Research Report

 Published Date : Oct-2018   |    Format :PDF |    Number of Pages : 110   |    Publisher : Extense Research

This report studies the global market size of Nuclear Medicine/Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine/Radiopharmaceuticals in these regions.
This research report categorizes the global Nuclear Medicine/Radiopharmaceuticals market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.
In 2017, the global Nuclear Medicine/Radiopharmaceuticals market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine/Radiopharmaceuticals market based on company, product type, application and key regions.

The various contributors involved in the value chain of Nuclear Medicine/Radiopharmaceuticals include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Nuclear Medicine/Radiopharmaceuticals include
    China Isotope & Radiation
    Dongcheng
    Jaco
    Ciaeriar
    Advanced Molecular-imaging Solution
    Shanghai Atom Kexing

Market Size Split by Type
    Diagnostic
    Therapeutic
Market Size Split by Application
    Oncology
    Thyroid
    Cardiology

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Nuclear Medicine/Radiopharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Nuclear Medicine/Radiopharmaceuticals market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Nuclear Medicine/Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Nuclear Medicine/Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Nuclear Medicine/Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceuticals are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine/Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Nuclear Medicine/Radiopharmaceuticals Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Type
        1.4.2 Diagnostic
        1.4.3 Therapeutic
    1.5 Market by Application
        1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application
        1.5.2 Oncology
        1.5.3 Thyroid
        1.5.4 Cardiology
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size
        2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue 2016-2025
        2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Sales 2016-2025
    2.2 Nuclear Medicine/Radiopharmaceuticals Growth Rate by Regions
        2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions
        2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
        3.1.1 Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers
        3.1.2 Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturers
        3.1.3 Global Nuclear Medicine/Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
    3.2 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers
        3.2.1 Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2018)
        3.2.2 Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2016-2018)
    3.3 Nuclear Medicine/Radiopharmaceuticals Price by Manufacturers
    3.4 Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Product Types
        3.4.1 Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Category
        3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type
    4.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type
    4.3 Nuclear Medicine/Radiopharmaceuticals Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Nuclear Medicine/Radiopharmaceuticals Breakdown Data by Application

6 North America
    6.1 North America Nuclear Medicine/Radiopharmaceuticals by Countries
        6.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        6.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Nuclear Medicine/Radiopharmaceuticals by Type
    6.3 North America Nuclear Medicine/Radiopharmaceuticals by Application
    6.4 North America Nuclear Medicine/Radiopharmaceuticals by Company

7 Europe
    7.1 Europe Nuclear Medicine/Radiopharmaceuticals by Countries
        7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        7.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Nuclear Medicine/Radiopharmaceuticals by Type
    7.3 Europe Nuclear Medicine/Radiopharmaceuticals by Application
    7.4 Europe Nuclear Medicine/Radiopharmaceuticals by Company

8 Asia Pacific
    8.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Countries
        8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Type
    8.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Application
    8.4 Asia Pacific Nuclear Medicine/Radiopharmaceuticals by Company

9 Central & South America
    9.1 Central & South America Nuclear Medicine/Radiopharmaceuticals by Countries
        9.1.1 Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        9.1.2 Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Nuclear Medicine/Radiopharmaceuticals by Type
    9.3 Central & South America Nuclear Medicine/Radiopharmaceuticals by Application
    9.4 Central & South America Nuclear Medicine/Radiopharmaceuticals by Company

10 Middle East and Africa
    10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Countries
        10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries
        10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Type
    10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Application
    10.4 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Company

11 Company Profiles
    11.1 China Isotope & Radiation
        11.1.1 China Isotope & Radiation Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceuticals
        11.1.4 Nuclear Medicine/Radiopharmaceuticals Product Description
        11.1.5 Recent Development
    11.2 Dongcheng
        11.2.1 Dongcheng Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceuticals
        11.2.4 Nuclear Medicine/Radiopharmaceuticals Product Description
        11.2.5 Recent Development
    11.3 Jaco
        11.3.1 Jaco Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceuticals
        11.3.4 Nuclear Medicine/Radiopharmaceuticals Product Description
        11.3.5 Recent Development
    11.4 Ciaeriar
        11.4.1 Ciaeriar Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceuticals
        11.4.4 Nuclear Medicine/Radiopharmaceuticals Product Description
        11.4.5 Recent Development
    11.5 Advanced Molecular-imaging Solution
        11.5.1 Advanced Molecular-imaging Solution Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceuticals
        11.5.4 Nuclear Medicine/Radiopharmaceuticals Product Description
        11.5.5 Recent Development
    11.6 Shanghai Atom Kexing
        11.6.1 Shanghai Atom Kexing Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Nuclear Medicine/Radiopharmaceuticals
        11.6.4 Nuclear Medicine/Radiopharmaceuticals Product Description
        11.6.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Nuclear Medicine/Radiopharmaceuticals Raw Material
        13.1.2 Nuclear Medicine/Radiopharmaceuticals Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Nuclear Medicine/Radiopharmaceuticals
    Figure Global Nuclear Medicine/Radiopharmaceuticals Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Production Market Share by Types (Product Category) in 2017
    Figure Diagnostic Product Picture
    Table Major Manufacturers of Diagnostic
    Figure Therapeutic Product Picture
    Table Major Manufacturers of Therapeutic
    Table Global Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Oncology
    Figure Thyroid
    Figure Cardiology
    Figure Nuclear Medicine/Radiopharmaceuticals Report Years Considered
    Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size 2016-2025 (Million US$)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales 2016-2025 (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions 2016-2025 (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions 2016-2025
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions 2016-2025
    Figure 2017 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions 2016-2025 (Million US$)
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions 2016-2025
    Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2016-2018) (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers (2016-2018)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Manufacturers in 2017
    Table Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2018) (Million US$)
    Table Nuclear Medicine/Radiopharmaceuticals Revenue Share by Manufacturers (2016-2018)
    Figure Nuclear Medicine/Radiopharmaceuticals Value Share by Manufacturers in 2017
    Table Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Nuclear Medicine/Radiopharmaceuticals Price (2016-2018) (USD/Unit)
    Table Nuclear Medicine/Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Nuclear Medicine/Radiopharmaceuticals Product Category
    Table Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceuticals Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2016-2025)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2025)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2017
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2016-2025) (Million US$)
    Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2016-2025)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2016-2025)
    Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type in 2017
    Table Nuclear Medicine/Radiopharmaceuticals Price by Type 2013-2018 (USD/Unit)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2016-2025)
    Figure Global Sales Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2016-2025)
    Figure Global Sales Nuclear Medicine/Radiopharmaceuticals Market Share by Application (2016-2025)
    Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2025) (K Units)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 North America Nuclear Medicine/Radiopharmaceuticals Market Share by Type
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2025) (K Units)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 North America Nuclear Medicine/Radiopharmaceuticals Market Share by Application
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Company (2016-2018) (K Units)
    Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2016-2018)
    Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2017
    Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure Germany Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (K Units)
    Figure France Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure France Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure UK Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Type
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Nuclear Medicine/Radiopharmaceuticals Market Share by Application
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Company (2016-2018) (K Units)
    Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2016-2018)
    Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2017
    Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure China Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure China Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure India Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Share by Type
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Share by Application
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2017
    Figure Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure Brazil Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Share by Type
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Nuclear Medicine/Radiopharmaceuticals Market Share by Application
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales by Company (2016-2018) (K Units)
    Table Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2016-2018)
    Figure Central & South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2017
    Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries
    Figure GCC Countries Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Nuclear Medicine/Radiopharmaceuticals Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Share by Type
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Share by Application
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Company in 2017
    Table China Isotope & Radiation Company Details
    Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table China Isotope & Radiation Recent Development
    Table Dongcheng Company Details
    Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Dongcheng Recent Development
    Table Jaco Company Details
    Table Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Jaco Recent Development
    Table Ciaeriar Company Details
    Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Ciaeriar Recent Development
    Table Advanced Molecular-imaging Solution Company Details
    Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Advanced Molecular-imaging Solution Recent Development
    Table Shanghai Atom Kexing Company Details
    Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Shanghai Atom Kexing Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Nuclear Medicine/Radiopharmaceuticals Value Chain
    Table Typical Suppliers of Key Nuclear Medicine/Radiopharmaceuticals Raw Material
    Table Nuclear Medicine/Radiopharmaceuticals Customers List
    Table Nuclear Medicine/Radiopharmaceuticals Sales Channels
    Table Nuclear Medicine/Radiopharmaceuticals Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@extentresearch.com